检索结果 - Mark Ozeck
- Showing 1 - 8 results of 8
-
1
Adenosine Receptor Activation Induces Vascular Endothelial Growth Factor in Human Retinal Endothelial Cells 由 Maria B. Grant, Roy Tarnuzzer, Sergio Caballero, Mark Ozeck, Margaret I. Davis, Polyxenie E. Spoerri, Igor Feoktistov, Italo Biaggioni, John C. Shryock, Luiz Belardinelli
出版 1999Artigo -
2
PEST Domain Mutations in Notch Receptors Comprise an Oncogenic Driver Segment in Triple-Negative Breast Cancer Sensitive to a γ-Secretase Inhibitor 由 Kai Wang, Qin Zhang, Danan Li, Keith A. Ching, Cathy Zhang, Xianxian Zheng, Mark Ozeck, Stephanie Shi, Xiaorong Li, Hui Wang, Paul A. Rejto, James G. Christensen, Peter Olson
出版 2015Artigo -
3
-
4
An Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735 由 Kenneth E. Hook, Scott J. Garza, Maruja E. Lira, Keith A. Ching, Nathan V. Lee, Joan Cao, Jing Yuan, Jingjing Ye, Mark Ozeck, Stephanie T. Shi, Xianxian Zheng, Paul A. Rejto, Julie L.C. Kan, James G. Christensen, Adam Pavlı́ček
出版 2012Artigo -
5
Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models 由 Cathy C. Zhang, Adam Pavlı́ček, Qin Zhang, Maruja E. Lira, Cory L. Painter, Zhengming Yan, Xianxian Zheng, Nathan V. Lee, Mark Ozeck, Ming Qiu, Qing Zong, Patrick B. Lappin, Anthony Wong, Paul A. Rejto, Tod Smeal, James G. Christensen
出版 2012Artigo -
6
HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib 由 Douglas D. Fang, Bin Zhang, Qingyang Gu, Maruja E. Lira, Qiang Xu, Hongye Sun, Maoxiang Qian, Weiqi Sheng, Mark Ozeck, Zhenxiong Wang, Cathy Zhang, Xinsheng Chen, Kevin X. Chen, Jian Li, Shu‐Hui Chen, James G. Christensen, Mao Mao, Chi-Chung Chan
出版 2014Artigo -
7
A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma 由 Cristina Papayannidis, Daniel J. DeAngelo, Wendy Stock, Bo Huang, M. Naveed Shaik, Rossano Cesari, Xianxian Zheng, Jennifer M. Reynolds, Patricia A. English, Mark Ozeck, Jon C. Aster, Frank C. Kuo, Donghui Huang, Paul D. Lira, Karen R. McLachlan, Kenneth A. Kern, Guillermo Garcia‐Manero, Giovanni Martinelli
出版 2015Carta -
8
A<i>NOTCH1</i>gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer 由 John J. Arcaroli, Wan‐Tien Tai, Ryan McWilliams, Stacey M. Bagby, Patrick J. Blatchford, Marileila Varella‐Garcia, Alicia Purkey, Kevin S. Quackenbush, Eun‐Kee Song, Todd M. Pitts, Dexiang Gao, Chris Lieu, Martine C. McManus, Aik Choon Tan, Xianxian Zheng, Qin Zhang, Mark Ozeck, Peter Olson, Zhi-Qin Jiang, Scott Kopetz, Antonio Jimeno, Stephen B. Keysar, Gail Eckhardt, Wells A. Messersmith
出版 2015Artigo
相关主题
Biology
Cancer research
Medicine
Cancer
Gene
Genetics
Internal medicine
Oncology
Anaplastic lymphoma kinase
Biomarker
Breast cancer
Chemistry
Colorectal cancer
Crizotinib
Fusion gene
Lung cancer
Malignant pleural effusion
Molecular biology
Notch signaling pathway
Receptor
ALK inhibitor
Acute lymphocytic leukemia
Adenocarcinoma
Adenosine
Adenosine A1 receptor
Adenosine A2B receptor
Adenosine A3 receptor
Adenosine receptor
Adenosine receptor antagonist
Agonist